COVID-19

Displaying 61 - 80 of 185

Publications

EMCDDA trendspotter briefing: Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in east European Neighbourhood Policy countries

28.09.2020

Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to the progressive introduction of social distancing and other control measures by national governments. To investigate the...

News

COVID-19 disruption and a strong drug market bring new threats to health and security in Europe

22.09.2020

High availability across all drug types, drug production within Europe and highly potent substances are among the concerns addressed today by the EU drugs agency (EMCDDA) in its European Drug Report 2020: Trends and Developments (1). In its latest annual review — marking 25 years of monitoring —...

Publications

European Drug Report 2020: Trends and Developments

22.09.2020

This report provides a comprehensive analysis of patterns emerging across Europe in the areas of drug supply, illicit drug use and associated public health problems. National data sets are also provided across these themes and on key harm-reduction interventions. The report is available in English...

Publications

European Drug Report 2020: Key Issues

22.09.2020

This report, available in 24 languages, presents a summary of some the main findings of the 'European Drug Report 2020: Trends and Developments the EMCDDA’s latest analysis of the drug situation in Europe. The issues selected here have been chosen for their policy relevance and general interest.

Events

Focus group 2: meeting on the impact of the Covid-19 pandemic on patterns of drug use and drug services in the Western Balkans

07.08.2020

The EMCDDA is carrying out an information gathering exercise using the trendspotter methodology. The objective is to map and increase our understanding of the impact of the COVID-19 and the...

Document library

Infection prevention and control and surveillance for coronavirus disease (COVID-19) in prisons in EU/EEA countries and the UK

08.07.2020

This document provides principles of surveillance, infection prevention and control (IPC) and management of COVID-19 infection in prisons in European Union (EU) and European Economic Area (EEA)...

Events

EMCDDA webinar: COVID-19 and drug policy

07.07.2020

The EMCDDA is offering a new series of webinars around the theme of COVID-19. The purpose of the webinars is to help those working in the drugs field understand how drug users, and those supporting...

Events

Focus group 1: Meeting on the impact of the Covid-19 pandemic on patterns of drug use and drug services in the Western Balkans

02.07.2020

The EMCDDA is carrying out an information gathering exercise using the trendspotter methodology. The objective is to map and increase our understanding of the impact of the COVID-19 and the...

Events

EMCDDA webinar: COVID-19 and drug supply via darknet markets

01.07.2020

Document library

COVID-19, drug consumption and addiction in Spain

01.07.2020

The COVID 19 epidemic has had a major impact on people's daily lives and is an unprecedented challenge for health services that care for people with addiction. In order to know the potential impact...

Events

Virtual event on lessons learned from the impact of COVID-19 on the drug situation in Europe

30.06.2020

The EMCDDA will be joined by a range of its external partners in a virtual event following on from International day against drug abuse and illicit trafficking (26 June). The meeting is a symbolic...

News

EMCDDA welcomes external partners to virtual event on lessons learned from the impact of COVID-19 on the drug situation in Europe

30.06.2020

The EMCDDA will be joined by a range of its external partners today in a virtual event following on from International day against drug abuse and illicit trafficking (26 June). The meeting is a symbolic gathering of representatives of the European Commission, the Permanent Missions representing the...

News

Speech by Alexis Goosdeel: Closing remarks on the impact of the COVID-19 pandemic on the world drug situation — the European perspective

26.06.2020

Occasion: Closing remarks on the impact of the COVID-19 pandemic on the world drug situation — the European perspective Thank you Chairperson and colleagues, I am pleased to provide some closing remarks to this CND special event commemorating the United Nations International day against drug...

News

EMCDDA and Europol join EU institutions in dialogue on the impact of COVID-19 on the world drug situation

26.06.2020

On the occasion of International day against drug abuse and illicit trafficking, the EMCDDA and Europol are joining representatives of the EU institutions today in providing the European perspective on the impact of COVID-19 on the world drug situation. The panel discussion will conclude a special...

Publications

EMCDDA Trendspotter briefing: impact of COVID-19 on patterns of drug use and drug-related harms in Europe

23.06.2020

Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this pandemic for people who use drugs in Europe, the EMCDDA instigated a mixed-...

News

COVID-19: New EMCDDA study highlights decline in stimulant drug use but some rises in the use of cannabis, alcohol and prescription medicines to combat anxiety and depression

23.06.2020

A decline in stimulant drug use but some rises in the consumption of cannabis and licit substances are among the findings presented today in a new EMCDDA report The impact of COVID-19 on patterns of drug use and drug-related harms in Europe. The report describes how national confinement measures...